1. Mizagliflozin, a selective SGLT1 inhibitor, improves vascular cognitive impairment in a mouse model of small vessel disease. Issue 5 (29th September 2021) Authors: Ishida, Nanae; Saito, Maki; Sato, Sachiko; Tezuka, Yu; Sanbe, Atsushi; Taira, Eiichi; Hirose, Masamichi Journal: Pharmacology research & perspectives Issue: Volume 9:Issue 5(2021) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. SGLT1 participates in the development of vascular cognitive impairment in a mouse model of small vessel disease. (14th May 2020) Authors: Ishida, Nanae; Saito, Maki; Sato, Sachiko; Koepsell, Hermann; Taira, Eiichi; Hirose, Masamichi Journal: Neuroscience letters Issue: Volume 727(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗